Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.

MLA

Walsh, Karin S., et al. “Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.” Neurology. Genetics, vol. 7, no. 5, Aug. 2021, p. e616. EBSCOhost, https://doi.org/10.1212/NXG.0000000000000616.

APA

Walsh, K. S., Wolters, P. L., Widemann, B. C., Del Castillo, A., Sady, M. D., Inker, T., Roderick, M. C., Martin, S., Toledo-Tamula, M. A., Struemph, K., Paltin, I., Collier, V., Mullin, K., Fisher, M. J., & Packer, R. J. (2021). Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1. Neurology. Genetics, 7(5), e616. https://doi.org/10.1212/NXG.0000000000000616

Chicago

Walsh, Karin S, Pamela L Wolters, Brigitte C Widemann, Allison Del Castillo, Maegan D Sady, Tess Inker, Marie Claire Roderick, et al. 2021. “Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.” Neurology. Genetics 7 (5): e616. doi:10.1212/NXG.0000000000000616.